Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20268 Citations
NAD+ injectable protocols produce rapid cellular energy restoration and sirtuin activation. A 2019 IV infusion study confirmed 398% plasma elevation above baseline. Subcutaneous maintenance dosing at 100 to 250 mg twice weekly is the community standard for longevity use, though RCT evidence for wellness claims is still catching up.
100mcg · 2x/week
Summary: Add 5mL BAC water to your 500mg vial. Draw to 0.1 units on a U-100 syringe for a 100mcg dose. This vial will last 5000 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mg | 2x/week |
| Moderate | 250mg | 2x/week |
| Aggressive | 500mg | 3x/week |
Your 500 mg vial with 5 mL bacteriostatic water gives you 100 mg/mL. At 100 mg per dose, that's 1.0 mL (100 units on a U-100 insulin syringe), so one vial covers 5 doses. If you're running 250 mg doses, reconstitute with 2 mL instead: that gives 250 mg/mL, and each dose is 1.0 mL. Trying to pull 2.5 mL for a 250 mg dose from a standard 5 mL reconstitution is impractical for a single subcutaneous site. Inject slowly. Thirty to sixty seconds minimum. The sting is the number one complaint in every forum thread, and speed is almost always the cause. Warm the syringe in your palm for a minute before injecting. Morning dosing is the standard; some users report sleep disruption with evening administration. One thing most beginners miss: cloudiness or any visible precipitate means discard the vial. NAD+ degrades with heat and agitation. Add the water slowly down the vial wall and swirl gently. Never shake it.
Dosing based on Community dosing consensus from peptide research communities — 12 published references.View all sources →
Cross-check your NAD+ reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
NAD+ injectable protocols produce rapid cellular energy restoration and sirtuin activation. A 2019 IV infusion study confirmed 398% plasma elevation above baseline. Subcutaneous maintenance dosing at 100 to 250 mg twice weekly is the community standard for longevity use, though RCT evidence for wellness claims is still catching up.